See other bills
under the
same topic
        PRIOR PRINTER'S NO. 92                        PRINTER'S NO. 1584

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 111 Session of 1999


        INTRODUCED BY DERMODY, GANNON, BLAUM, PESCI, M. COHEN, BISHOP,
           READSHAW, CALTAGIRONE, TRELLO, PRESTON, WALKO, MAITLAND,
           WASHINGTON, DALEY, HARHAI, SURRA, STEELMAN, MAHER, HORSEY AND
           SERAFINI, JANUARY 25, 1999

        AS REPORTED FROM COMMITTEE ON JUDICIARY, HOUSE OF
           REPRESENTATIVES, AS AMENDED, APRIL 20, 1999

                                     AN ACT

     1  Amending the act of April 14, 1972 (P.L.233, No.64), entitled
     2     "An act relating to the manufacture, sale and possession of
     3     controlled substances, other drugs, devices and cosmetics;
     4     conferring powers on the courts and the secretary and
     5     Department of Health, and a newly created Pennsylvania Drug,
     6     Device and Cosmetic Board; establishing schedules of
     7     controlled substances; providing penalties; requiring
     8     registration of persons engaged in the drug trade and for the
     9     revocation or suspension of certain licenses and
    10     registrations; and repealing an act," regulating gamma
    11     hydroxybutrate HYDROXYBUTYRIC acid; PROHIBITING CERTAIN        <--
    12     ADVERTISEMENTS BY ELECTRONIC TRANSMISSION; AND FURTHER
    13     PROVIDING FOR PROHIBITED ACTS.

    14     The General Assembly of the Commonwealth of Pennsylvania
    15  hereby enacts as follows:
    16     Section 1.  Section 4(4) of the act of April 14, 1972          <--
    17  (P.L.233, No.64), known as The Controlled Substance, Drug,
    18  Device and Cosmetic Act, amended November 26, 1978 (P.L.1392,
    19  No.328), is amended to read:
    20     SECTION 1.  SECTION 4(3) OF THE ACT OF APRIL 14, 1972          <--
    21  (P.L.233, NO.64), KNOWN AS THE CONTROLLED SUBSTANCE, DRUG,
    22  DEVICE AND COSMETIC ACT, IS AMENDED BY ADDING A SUBCLAUSE TO

     1  READ:
     2     Section 4.  Schedules of Controlled Substances.--The
     3  following schedules include the controlled substances listed or
     4  to be listed by whatever official name, common or usual name,
     5  chemical name, or trade name designated.
     6     * * *
     7     (4)  Schedule IV--In determining that a substance comes        <--
     8  within this schedule, the secretary shall find: a low potential
     9  for abuse relative to substances in Schedule III; currently
    10  accepted medical use in the United States; and limited physical
    11  and/or psychological dependence liability relative to the
    12  substances listed in Schedule III. The following controlled
    13  substances are included in this schedule:
    14     (i)  Any material, compound, mixture, or preparation, unless
    15  specifically excepted or unless listed in another schedule,
    16  which contains any quantity of the following substances:
    17     1.  Barbital.
    18     2.  Chloral betaine.
    19     3.  Chloral hydrate.
    20     4.  Ethchlorvynol.
    21     5.  Ethinamate.
    22     6.  Methohexital.
    23     7.  Meprobamate.
    24     8.  Methylphenobarbital.
    25     9.  Paraldehyde.
    26    10.  Petrichloral.
    27    11.  Phenobarbital.
    28     (i.1)  Gamma hydroxybutrate acid.
    29     (ii)  The secretary may by regulation except any compound,
    30  mixture, or preparation containing any drug or controlled
    19990H0111B1584                  - 2 -

     1  dangerous substance listed in subclause (i) of this schedule
     2  above from the application of those provisions of this act
     3  covering controlled drugs, if the compound, mixture, or
     4  preparation contains one or more active medicinal ingredients
     5  not having a stimulant or depressant effect on the central
     6  nervous system: Provided, That such admixtures shall be included
     7  therein in such combinations, quantity, proportion, or
     8  concentration as to vitiate the potential for abuse of the
     9  substances which do have a stimulant or depressant effect on the
    10  central nervous system.
    11     (iii)  The secretary shall by regulation exempt any
    12  nonnarcotic substance from the control under this act if such
    13  substance may, under the provisions of the Federal Food, Drug,
    14  and Cosmetic Act (21 U.S.C. 301 et seq.), be lawfully sold over
    15  the counter without a prescription.
    16     * * *
    17     (3)  SCHEDULE III--IN DETERMINING THAT A SUBSTANCE COMES       <--
    18  WITHIN THIS SCHEDULE, THE SECRETARY SHALL FIND: A POTENTIAL FOR
    19  ABUSE LESS THAN THE SUBSTANCES LISTED IN SCHEDULES I AND II;
    20  WELL DOCUMENTED AND CURRENTLY ACCEPTED MEDICAL USE IN THE UNITED
    21  STATES; AND ABUSE MAY LEAD TO MODERATE OR LOW PHYSICAL
    22  DEPENDENCE OR HIGH PSYCHOLOGICAL DEPENDENCE. THE FOLLOWING
    23  CLASSES OF CONTROLLED SUBSTANCES ARE INCLUDED IN THIS SCHEDULE:
    24     * * *
    25     (VIII)  GAMMA HYDROXYBUTYRIC ACID, ANY SALT, COMPOUND
    26  DERIVATIVE OR PREPARATION OF GAMMA HYDROXYBUTYRIC ACID,
    27  INCLUDING ANY ISOMERS, ESTERS AND ETHERS AND SALTS OF ISOMERS
    28  AND ESTERS AND ETHERS OF GAMMA HYDROXYBUTYRIC ACID WHENEVER THE
    29  EXISTENCE OF SUCH ISOMERS, ESTERS, ETHERS AND SALTS IS POSSIBLE
    30  WITHIN THE SPECIFIC CHEMICAL DESIGNATION.
    19990H0111B1584                  - 3 -

     1     * * *
     2     SECTION 2.  SECTION 13(A)(34) OF THE ACT IS AMENDED AND THE
     3  SECTION IS AMENDED BY ADDING A SUBSECTION TO READ:
     4     SECTION 13.  PROHIBITED ACTS; PENALTIES.--(A)  THE FOLLOWING
     5  ACTS AND THE CAUSING THEREOF WITHIN THE COMMONWEALTH ARE HEREBY
     6  PROHIBITED:
     7     * * *
     8     (34)  THE PLACING IN ANY NEWSPAPER, MAGAZINE, HANDBILL OR
     9  OTHER PUBLICATION OR BY WRITTEN OR ELECTRONIC MEANS, INCLUDING
    10  ELECTRONIC MAIL, INTERNET, FACSIMILE AND SIMILAR TRANSMISSION,
    11  ANY ADVERTISEMENT, KNOWING, OR UNDER CIRCUMSTANCES WHERE ONE
    12  REASONABLY SHOULD KNOW, THAT THE PURPOSE OF THE ADVERTISEMENT,
    13  IN WHOLE OR IN PART IS TO PROMOTE THE SALE OF OBJECTS DESIGNED
    14  OR INTENDED FOR USE AS DRUG PARAPHERNALIA.
    15     * * *
    16     (N)  ANY PERSON WHO VIOLATES SUBSECTION (A)(12), (14), (16),
    17  (30) OR (34) WITH RESPECT TO GAMMA HYDROXYBUTYRIC ACID, ANY
    18  SALT, COMPOUND DERIVATIVE OR PREPARATION OF GAMMA HYDROXYBUTYRIC
    19  ACID, INCLUDING ANY ISOMERS, ESTERS AND ETHERS AND SALTS OF
    20  ISOMERS, OR ESTERS AND ETHERS OF GAMMA HYDROXYBUTYRIC ACID
    21  WHENEVER THE EXISTENCE OF SUCH ISOMERS, ESTERS, ETHERS OR SALTS
    22  IS POSSIBLE WITHIN THE SPECIFIC CHEMICAL DESIGNATION, IS GUILTY
    23  OF A FELONY AND UPON CONVICTION THEREOF SHALL BE SENTENCED TO
    24  IMPRISONMENT NOT EXCEEDING FIFTEEN YEARS, OR TO PAY A FINE NOT
    25  EXCEEDING TWO HUNDRED FIFTY THOUSAND DOLLARS ($250,000), OR
    26  BOTH, OR SUCH LARGER AMOUNT AS IS SUFFICIENT TO EXHAUST THE
    27  ASSETS UTILIZED IN AND THE PROFITS OBTAINED FROM THE ILLEGAL
    28  ACTIVITY.
    29     Section 2 3.  This act shall take effect immediately.          <--

    A5L35JRW/19990H0111B1584         - 4 -